UK markets closed

FibroGen, Inc. (FGEN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.1400+0.0100 (+0.88%)
At close: 04:00PM EDT
1.1500 +0.01 (+0.88%)
After hours: 07:57PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-284,232
-284,232
-293,654
-290,023
-189,291
Depreciation & amortisation
9,930
9,930
10,604
14,809
22,047
Stock-based compensation
50,767
50,767
65,601
71,161
72,720
Change in working capital
-119,687
-119,687
70,430
60,083
174,630
Accounts receivable
3,433
3,433
765
25,180
-11,973
Inventory
-1,695
-1,695
-10,999
-14,158
-9,175
Accounts payable
-15,514
-15,514
5,909
805
17,731
Other working capital
-317,540
-317,540
-184,674
-112,418
77,608
Other non-cash items
32,370
32,370
1,036
60,000
202
Net cash provided by operating activities
-315,021
-315,021
-145,933
-82,232
81,602
Cash flows from investing activities
Investments in property, plant and equipment
-2,519
-2,519
-38,741
-30,186
-3,994
Acquisitions, net
-
-
0
0
-3,896
Purchases of investments
-251,830
-251,830
-164,023
-484,144
-8,192
Sales/maturities of investments
407,350
407,350
291,874
87,358
467,506
Net cash used for investing activities
153,657
153,657
89,116
-426,972
452,487
Cash flows from financing activities
Debt repayment
-484
-484
-538
-5,892
-13,023
Common stock issued
48,407
48,407
0
0
37,829
Other financing activities
-2,983
-2,983
43,130
-7,372
-11,463
Net cash used provided by (used for) financing activities
122,749
122,749
46,776
-563
13,343
Net change in cash
-42,012
-42,012
-15,523
-507,170
552,127
Cash at beginning of period
155,700
155,700
171,223
678,393
126,266
Cash at end of period
113,688
113,688
155,700
171,223
678,393
Free cash flow
Operating cash flow
-315,021
-315,021
-145,933
-82,232
81,602
Capital expenditure
-2,519
-2,519
-38,741
-30,186
-3,994
Free cash flow
-317,540
-317,540
-184,674
-112,418
77,608